|Day Low/High||28.28 / 29.60|
|52 Wk Low/High||28.72 / 300.00|
The secondary offering of the producer of plant-based meat substitutes is priced well below its Wednesday's close.
Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced today it will report results for the second quarter ended June 30, 2019 on Tuesday, August 13, 2019 after market close.
There should also be some news out of China as trade negotiations resume.
So many stocks, so much news, so little time. The good news is I'm letting you borrow my shovel.
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
Ladenburg Thalmann initiated coverage of the cannabis sector, with preference for companies focused on long-term value creation.
Tilray Inc. (TLRY:NASDAQ), a global pioneer in cannabis cultivation, processing and distribution, today announced that it has successfully imported Good Manufacturing Practices (GMP)-certified finished medical cannabis oral solutions into Ireland intended...
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announces the expansion of its European leadership team with the appointment of Arne Wilkens as Vice President, Business Expansion, Europe;...
There is a lot of buzz about the pot industry from legislation to consolidation to investing. Watch the video to learn how technology could be the key to cannabis success.
Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing Practices...
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy Growth stock is taking a beating on Friday after the company disappointed investors with its quarterly results. Here's the must-hold support level for the stock now.
Gainers lead losers 10 to five in cannabis sector ahead of Canopy Growth report.
Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research, cultivation and distribution, today announced the expansion of its global senior leadership team with the appointment of Kristina Adamski as Executive Vice President, Corporate...
Neptune Wellness shares jump after the pot extraction and purification company announces it has struck a deal to with cannabis company Green Organic Dutchman Holdings.
The point was that there are certain stocks that are traded without regard to valuations or fundamentals.
There's no way to play the stock of the meat alternative provider unless you are a kamikaze daredevil with a very deep pocketbook.
Stocks ended up Monday following President Trump's 'indefinite' suspension of tariffs planned on goods imported from Mexico and on big mergers in the defense and tech sectors.
Tilray is erupting higher and breaking over downtrend resistance. It's been a long time coming for this troubled cannabis stock.
Canadian pot producer Tilray announces a deal with majority shareholder Privateer Holdings to gradually sell the private equity firm's remaining stake in it.
Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that it has signed a non-binding Letter of Intent ("LOI") with its largest stockholder Privateer Holdings, Inc.
Neptune Wellness soars after reaching a deal to provide extraction and purification services for Tilray.
LAVAL, QC, June 7, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), has entered into a definitive agreement to provide extraction, and purification services to Tilray Inc.
Bank of America lifts its price target on Cronos to $20 from $13.
Tilray, Inc., ("Tilray" or the "Company") (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today announced that management will present at the following upcoming investor events: On Thursday, June 6, 2019, the...
The FDA will discuss the safety and product quality of CBD-derived compounds in a public hearing Friday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.